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Abstract. Peripheral node addressin (PNAd) is a com- 
plex mixture of glycoproteins with L-selectin ligand ac- 
tivity that functions in lymphocyte homing. We have in- 
vestigated the contribution of the sialomucin CD34 
relative to other components of PNAd in lymphocyte 
tethering and rolling in in vitro laminar flow assays. 
PNAd was isolated with MECA-79 mAb-Sepharose 
from tonsillar stroma, and the CD34 component 
(PNAd,CD34 ÷) and CD34-negative component 
(PNAd,CD34-) separated on CD34 mAb-Sepharose. 
Lymphocytes on the PNAd,CD34- fraction tether less 
efficiently, roll faster and are less resistant to shear de- 
tachment than on PNAd. The PNAd,CD34 ÷ fraction 
constitutes about half the total functional activity. 
These studies show that CD34 is a major functional 
component of PNAd. Ligand activity in both the 
PNAd,CD34 + and PNAd,CD34- fractions is expressed 
on mucin-like domains, as shown with O-sialoglycopro- 
tease. The CD34 component of PNAd has about four 
times higher tethering efficiency than total tonsillar 
CD34. CD34 from spleen shows no lymphocyte tether- 
ing. Although less efficient than the PNAd,CD34 + frac- 
tion from tonsil, CD34 from the KGla hematopoietic 
cell line is functionally active as an L-selectin ligand de- 
spite lack of reactivity with MECA-79 mAb, which 
binds to a sulfation-dependent epitope. All four forms 
of CD34 are active in binding to E-selectin. KGla 
CD34 but not spleen CD34 are active as L-selectin 
ligands, yet both lack MECA-79 reactivity and possess 
E-selectin ligand activity. This suggests that L-selectin 
ligands and E-selectin ligands differ in more respects 
than presence of the MECA-79 epitope. 
-SELECTIN is important in several types of leukocyte in- 
teractions with vascular endothelium (32). L-selec- 
tin was initially identified on lymphocytes as a re- 
ceptor for high endothelial venules (HEV)  1 of peripheral 
lymph nodes  and shown to be important in lymphocyte 
homing or recirculation (14, 41). Subsequently, L-selectin 
was found also to be expressed on neutrophils, monocytes, 
and eosinophils, and to be important in rolling interactions 
of neutrophils in post capillary venules of inflamed tissues 
and in accumulation of leukocytes at inflammatory sites 
(33, 49). 
Studies on the carbohydrate ligands for L-selectin and 
the  glycoproteins bearing these ligands  have focused on 
molecules expressed in HEV. The rat  anti-mouse  mAb 
MECA-79 binds specifically to HEV, inhibits binding of 
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lymphocytes to HEV, and identifies a carbohydrate anti- 
genic determinant closely associated  with  the L-selectin 
ligand (23, 47). Affinity purification with MECA-79 mAb 
or recombinant L-selectin yields a collection of glycopro- 
tein bands that appear nearly identical in SDS-PAGE, and 
have been termed the peripheral node addressin (PNAd) 
(6, 22). Sialylation and sulfation of PNAd are required for 
ligand  activity,  and  specific  oligosaccharide  structures 
bearing these modifications that are present in PNAd have 
been identified, but not yet associated with ligand activity 
(21). MECA-79 mAb cross-reacts with human PNAd, and 
as in the mouse is completely specific for HEV, as shown 
by immunohistochemistry of lymphoid tissues (36). PNAd 
isolated from human  tonsil is  a  ligand for L-selectin (6) 
and  supports  tethering  and  rolling  of lymphocytes and 
neutrophils in shear flow (31).  Affinity chromatography 
on  recombinant  L-selectin-Sepharose has  been  used  to 
isolate murine PNAd, and identify two of its components, 
GIyCAM-1 (28) and CD34 (4). Both molecules contain ex- 
tensive mucin-like segments that bear sulfated, sialylated 
O-linked oligosaccharides (22).  GlyCAM-1  is  a  secreted 
molecule  limited  in  expression  to  HEV  and  lactating 
mammary gland (10, 28). CD34 is a transmembrane glyco- 
protein expressed on many vascular endothelia including 
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genesis,  and  is  also  present  on  hematopoietic precursor 
cells (5, 12). Electron microscopy of capillary endothelium 
has  shown  that  the  CD34  molecule  is  luminal  and  con- 
centrated on membrane processes at endothelial junctions, 
a  critical zone  for leukocyte  adhesion,  and  migration  at 
sites of inflammation (12). Thus, CD34 is a candidate for 
an  L-selectin counter-receptor that  presents carbohydrate 
ligands both on HEV in lymphoid organs and also on less 
specialized vessels in non-lymphoid tissues. However, the 
function of CD34 in cell adhesion remains to be character- 
ized.  Thus  far,  only small  quantities  have  been  isolated 
from  murine  lymph  nodes,  and  functional  studies  have 
been limited  to demonstrating that soluble,  radiolabeled 
CD34 can be isolated with L-selectin affinity matrices (4, 
22). CD34 has not been demonstrated to support lympho- 
cyte  or  neutrophil  adhesion,  either  in  static  or  in  flow 
assays. Antibodies to CD34 have not been reported to in- 
hibit  L-selectin-dependent  adhesion.  Multiple  glycopro- 
tein  components  are  present  in  PNAd,  and  the  contri- 
bution  of CD34  relative  to  other  PNAd  components in 
adhesive interactions has been unclear. 
In this study, we have examined the role of CD34 in me- 
diating  lymphocyte tethering  and  roiling  under  in  vitro 
flow conditions,  and determined  its contribution relative 
to other components in the PNAd complex. We isolated 
PNAd from human tonsil,  and separated CD34 from the 
other components. CD34 has previously been shown to be 
well expressed on HEV in tonsil sections (17), but its func- 
tion has not been characterized, and it has not previously 
been  shown  to  be present  in  human  PNAd.  Studies  on 
lymphocyte  tethering,  rolling,  and  resistance  to  detach- 
ment in shear flow show that  CD34  is responsible for a 
majority  of adhesive  activity.  MECA-79-reactive  CD34 
from tonsil is more efficient as an L-selectin ligand than 
total tonsil  CD34.  Furthermore,  we  compare  CD34  iso- 
lated from tonsil, spleen, and KGla cells. We demonstrate 
that spleen CD34 is inactive, and KGla cell CD34 is 10% 
as active as tonsillar MECA-79 ÷ CD34.  KGla cell CD34 
lacks  MECA-79  reactivity  and  may present  a  carbohy- 
drate that is a model for a lower avidity L-selectin ligand 
such  as  found  on  leukocytes  (3)  and  on  postcapillary 
venules in non-lymphoid tissues (33, 50). 
Materials and Methods 
Monoclonal Antibodies and Cell Lines 
The CD34 mAb 581  (IgG1), 563  (IgGl, kappa), and 547  (IgG2a, kappa) 
were produced as described (15) and have been characterized (18).  Anti- 
bodies were purified by protein A  affinity chromatography. Monoclonals 
581 and 547 were biotinylated using biotin N-hydroxysuccinimide (Sigma 
Chemical Co., St. Louis, MO) active ester as described (19).  My-10 mAb 
to CD34 (IgG1, kappa) (9) was purified using protein A-Sepharose from 
culture supernatants. The hybridoma was obtained from the American 
Type Culture Collection (ATCC, Rockville, MD). 
MECA-79 mAb (rat IgM kappa)  (47) was a  generous gift of Dr. Eu- 
gene Butcher (Stanford, CA). Purified DREG-56 (IgG1) mAb to L-selec- 
tin (25) was used at 10 Ixg/ml. X63 (myeloma, IgG1) was used as a control 
at  1:5 dilution of culture supernatant. Hematopoietic progenitor KGla 
cells (ATCC) and CHO cells stably transfected with full-length human 
E-selectin (34) (CHO-E) were maintained in RPMI 1640 and a-MEM me- 
dium, respectively, containing 10%  heat-inactivated FBS,  5  mM gluta- 
mine, and 50 Ixg/ml gentamycin. Cells were harvested by a 10 min incuba- 
tion with H/H medium containing 5 mM EDTA at 37°C. Cells were washed 
and resuspended in the same medium at 2 ×  107 cells/ml and kept at room 
temperature until use. 
Lymphocytes 
Mononuclear cells were isolated from citrate anti-coagulated whole blood 
by  dextran-sedimentation followed  by  density separation  over  Ficoll- 
Hypaque (37).  Lymphocytes were prepared by incubating the mononu- 
clear cells on tissue culture dishes for 1 h and collecting the nonadherent 
cells. Lymphocytes (>97%)  were stored in HBSS (Ca  2+ and Mg  2+ free; 
GIBCO BRL, Gaithersburg, MD), 10 mM Hepes, pH 7.3, 0.5% human se- 
rum albumin (HSA). Cells were washed with and suspended in H/H bind- 
ing medium (Ca  2+- and Mg2+-free HBSS containing 2 mM CaC12, 0.2% 
HSA, and 10 mM Hepes, pH 7.3) before flow assays. 
Immunoaffinity Purification  and Blotting of Peripheral 
Node Addressin and CD34 
PNAd (MECA-79 antigen) from human tonsil and CD34 from human 
tonsil, spleen and KGla cells were isolated using sequential WGA-aga- 
rose (Sigma) and immunoaffinity chromatography. In a  typical purifica- 
tion, ~10 g fresh human tonsils (Children's Hospital, Boston, MA), after 
removal of any blood clots, were minced with scissors on a stainless steel 
screen (200 mesh =  74 Ixm, Type 316; Tylinter, Mentor, Ohio). Lympho- 
cytes that passed through the screen were eliminated by frequent flushing 
with RPMI-1640 medium (16). Stromal elements (8 g) remaining on the 
screen were collected. Tonsil stroma (8 g), human spleen (10 g), or KGla 
cells (10-ml pellet) were homogenized and detergent extracts prepared in 
250 ml of lysis buffer (2% Triton X-100, 150 mM NaCI, 0.02% NaN> 50 
mM Tris-HC1, pH 7.5 containing 10 I~g m1-1 each of aprotinin, pepstatin, 
and leupeptin, 1 mM of PMSF, 1 mM benzamidine, and 5 mM iodoacet- 
amide). After 1 h at 4°C the lysate was clarified by centrifugation (8,000 g 
for 30 rain) followed by filtration through 0.45-lxm filters and the superna- 
rants were passed over WGA-coupled (9 mg/ml, 5 ml) agarose columns. 
After washing, material was eluted with 0.5 M  N-acetylglucosamine, 150 
mM NaCI, 0.02% NaN  3, 50 mM Tris-HC1, pH 7.5 containing 1% octyl-[3- 
glucoside (OG) (WGA eluate). WGA eluates were passed through a con- 
trol  antibody-Sepharose  column and  then  a  column containing either 
MECA-79 mAb (2.64 mg/ml, 1.5 ml) or 581 mAb (2.5 mg/ml, 2 ml) cou- 
pled to Sepharose 4B  (Pharmacia Inc., Piscataway, NJ).  Columns were 
washed extensively (1% OG, 150 mM NaCI, 0.2 % NAN3, 50 mM Tris-HCl, 
pH 8.0) and eluted with 1% OG, 150 mM NaCI, 0.02% NaN3 in 0.2 M ace- 
tic acid for MECA-79 antigen (PNAd) or with 1%  OG, 150 mM NaCI, 
0.02% NaN> 20 mM triethanolamine, pH 11.8, for 581  antigen (CD34). 
Eluted material was neutralized by collecting fractions in 1/10 vol of 1 M 
Tris-HCl, pH 8.5 for MECA-79 antigen or pH 7.4 for CD34. Protein con- 
centrations were  determined using the bicinchoninic acid assay (Pierce 
Chem. Co., Rockford, Illinois). 
SDS-PAGE and Western blotting followed standard procedures (19, 
26). Immobilon-P blots were incubated with MECA-79 mAb (5 I*g/ml) or 
with  a  control  antibody,  followed  by  alkaline  phosphatase-conjugated 
mouse anti-rat IgM (kappa and lambda light chains; Sigma) and devel- 
oped according to manufacturer's instructions. 
For amino acid sequence analysis, purified PNAd was subjected to SDS 
7.5% PAGE, and electroblotted on PVDF membranes (Millipore). Bands 
were visualized with Ponceau-S (Sigma) and the major component at 105 
kD was excised and subjected to in situ trypsin digestion. Peptides were 
extracted from the membrane, separated using reversed phase columns, 
and sequenced (27). 
ELISA for CD34 
mAb 547 (10 ixg/ml in PBS, 50 ~l/well) was added to 96-well flat-bottom 
microtiter plates (Linbro, Flow Laboratories, McLean, Virginia) for 1 h at 
room temperature or overnight at 4°C. Wells were washed three times 
with PBS and blocked with 200 Ixl of 2% blot grade BSA (Promega Corp., 
Madison, WI) PBS for 1 h at 37°C. Wells were flicked empty and 50 Ixl of 
CD34 standards (twofold serial dilutions, 1,000 to 31.25  ng/ml) and sam- 
ples for CD34 estimation diluted in 1% BSA-PBS were added in triplicate 
for 1 h  at 37°C.  Wells were washed three times with PBS. Biotinylated 
mAb 581 (50 Ixl of 2 ixg/ml) was added for 30 min at 37°C. HRP-streptavi- 
din (Zymed, South San Francisco, CA) diluted 1:4,000  (50 txl) was added 
for 30 min at 37°C.  Wells were washed three times with PBS, once with 
2,2-azido-di(3-ethylbenzthiazoline) sulfonic acid (ABTS) substrate buffer 
(Zymed), and 50 ~1 of ABTS substrate buffer was then added. Plates were 
incubated at room temperature and read after 20 rain on a Dynatech Mi- 
crotiter ELISA reader (410 nm). Mean OD readings were calculated and 
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from the CD34 titration. 
CD34 Depletion  from PNAd 
581 mAb-Sepharosc 4B (125 pA wet bed, 2.5 mg/ml) was packed in a 10-ml 
polyprep chromatography column (Bio Rad Labs., Richmond, CA). The 
column was washed with the  elution  buffer (l%  OG,  150  mM  NaCl, 
0.02% NAN3, 20 mM triethanolamine, pH 11.8) and then equilibrated with 
the binding buffer (1%  OG, 150 mM NaCl, 0.02%  NAN3, Tris-HC1,  pH 
7.5). The column was allowed to drain by gravity and drops on the side of 
the column were removed. PNAd (500 ~1, 30 p,g/ml) was allowed to pass 
through the column and the flow-through was collected.  The flow-through 
was passed through again and this process repeated five times.  The col- 
umn was washed with six column volumes of binding buffer. The flow- 
through and washing were combined to obtain the PNAd,CD34  fraction. 
Bound CD34 was eluted with nine column volumes of elution buffer and 
neutralized  with  1/10 volumes of 1 M  Tris-HCl,  pH  7.5  to  obtain  the 
PNAd,CD34 + fraction.  In parallel,  another batch of PNAd was passed 
through a control mAb column (mouse IgG1) identically  as described for 
the CD34 mAb column and the same fractions collected.  Protein concen- 
trations were determined by bicinchoninic acid and by CD34 ELISA. Re- 
covery of PNAd protein when the depletion was carried out with the con- 
trol antibody column was >95%. This material is referred to as the PNAd 
fraction in functional experiments. 
Laminar Flow Assays 
Different PNAd fractions and immunopurified CD34 from tonsil,  spleen, 
and KGla cells were diluted at the indicated concentrations in TSA, pH 
7.5, and a final concentration of 0.1%  OG, and a 50-pA drop was adsorbed 
to plastic  slides overnight at 4°C. Nonspecific sites were blocked by incu- 
bating the plate with HBSS supplemented with 2%  HSA for 30 rain at 
room temperature. Substrate or HSA adsorbed slides were assembled in a 
parallel plate laminar flow chamber (260-p,m gap thickness) and mounted 
on the stage of an inverted phase-contrast microscope (Diaphot-TMD; Ni- 
kon Inc., Garden City,  NY), as previously described (29). Cells  were re- 
suspended at a concentration of 5 ×  105 m1-1 in the H/H binding medium 
for flow assays (30). Tethering, resistance to detachment, and rolling ve- 
locity  were measured twice  on different 10× microscopic fields  for each 
substrate containing an immobilized CD34 preparation or PNAd fraction. 
Cells were detached with 5 mM EDTA in H/H medium in between obser- 
vation on different fields. Three or four independent substrates on differ- 
ent days were prepared for each preparation or fraction, at three different 
concentrations each.  Data is reported as the average and SD of the three 
or four experiments. 
Tethering in flow was defined as the number of nonadherent cells that 
tethered within the field  of view and remained rollingly  adherent for at 
least 5 s. The number of cells that tethered in one minute was measured at 
different wall shear stresses. 
For detachment assays, cells were infused into the chamber at 0.84 dyn/ 
cm  2, allowed to adhere until equilibration between rolling and nonadher- 
ent cells  was reached  (~3  min) and  then the wall  shear stress was in- 
creased every 10 s to a maximum of 36 dyn/cm  2 to generate a detachment 
force.  The number of cells remaining bound was calculated  as a percent- 
age of the number of cells rolling on the substrate at 0.84 dyn/cm  2. 
Rolling velocities  were calculated as previously described (29) for 15 to 
20 of the cells observed during detachment assays.  Cell displacement was 
measured over 3-5-s intervals.  Velocities  were measured only for cells that 
remained adherent throughout the 10-s period during which a given shear 
was applied. 
Inhibitors 
To test CD34 mAbs, a  CD34 substrate to which tethering had  already 
been measured was incubated with a mixture of 10 I.Lg/ml  each of 547, 563, 
581, and My-10 mAb for 20 min. Tethering was in the presence of these 
mAb in the binding medium each at a concentration of 5 p~g/ml. For inhi- 
bition studies with L-selectin or control (IgG) mAbs, cells  (107/ml) were 
preincubated with 10 ~g/ml purified antibody for 10 min at room tempera- 
ture in binding medium. The cell suspension was diluted 20-fold in binding 
medium and immediately perfused into the flow chamber. Inhibition stud- 
ies with anionic polysaccharides were carried out at final concentrations of 
17.5 ~g/ml fucoidan, 20  ~g/ml heparin, and 30  ~g/ml of keratan sulfate 
from bovine cornea, all from Sigma. The antibody or the anionic polysac- 
charides were continuously present in the binding media, 
Enzyme Digestion 
A substrate to which tethering had already been measured was incubated 
with  Vibrio  cholera  neuraminidase  (5  mU/ml)  (Oxford  Glycosystems, 
Rosedale, NY) for 30 min in 50 mM sodium acetate, 4 mM CaCl2, 0.1% 
BSA, pH 5.5  or with O-sialoglycoprotease (0.2 mg/ml) (Cedarlane, On- 
tario, Canada) in the binding medium for 1 h at room temperature by in- 
jecting the enzyme through a side port of the flow chamber. The chamber 
was then washed with binding medium and tethering was measured to the 
same field. To study the effect of other glycosidases,  substrates were incu- 
bated with N-glycanase (2 U/ml) (Genzyme, Cambridge, MA) in 50 mM 
NaH2PO4,  pH 7.5, or endoq3-galactosidase (1  U/ml) (Oxford Glycosys- 
tems) in 50 mM sodium acetate, pH 5.8, and for each glycosidase,  20 p~M 
leupeptin, 30 tzM antipain, 1 mM benzamidine, and 0.02%  NaN  3 for 6 h at 
37°C. After the treatment the slides  were washed with PBS and blocked 
again with 2% HSA for 20 min at room temperature before the experi- 
ment. Several fields of view of substrates treated with glycosidase  or sham 
treated with buffer alone were monitored. 
Site Density Determination 
581  mAb  to  CD34  was iodinated  (7.5  ~.Ci/~g  specific  activity)  using 
IODO-BEADS (Pierce)  following the  instructions of the manufacturer 
and  site  densities of CD34  at the  concentrations used for flow experi- 
ments, were determined by saturation binding (11).  Protein samples (10 
~l) were coated at 4°C for 12 h, using removawell microtiter plates (Im- 
toulon 3; Dynatech Laboratories Inc.,  Chantilly,  VA), and other adsorp- 
tion sites on plastic were blocked with PBS containing 2% HSA. Saturat- 
ing concentrations of 125I-labeled mAb (2 Ixg/ml) in 50 ~xl binding medium 
(PBS/NaN3,  0.1%  HSA) were added to the wells and incubated for 1 h at 
22°C. The wells  were washed five times with binding medium, removed 
from the plate, and counted in a ~ counter. Specific binding was defined as 
counts min  1 bound to substrate-coated wells minus counts min  -1 bound 
to HSA-coated wells. Site  densities were calculated assuming binding of 
one IgG molecule per antigen molecule at saturation. All assays were per- 
formed in triplicate.  The values of sites per ixm  2 for PNAd,CD34 + fraction 
adsorbed at 440, 220, and 147 ng/ml for the flow assay were 287 -+ 35, 195 
-+ 27, and 96 --- 12, respectively.  Site densities/txm 2 for CD34 from KGla, 
spleen and tonsil adsorbed at 440 ng/ml were 300 -+ 37, 302 -+ 40, and 295 
-+ 30, respectively.  PNAd adsorbed at 1,460 ng/ml had 279 sites/~m  2 of 
CD34. 
Results 
A Prominent 105-kD Component of Human Tonsil 
PNAd Is the Sialomucin CD34 
WGA  affinity  chromatography  (28)  was  used  to  enrich 
L-selectin ligands in tonsil stroma detergent lysates. West- 
ern blots of the tonsil stromal lysate and the flow-through 
from the  WGA  column showed that  all  species  reactive 
with MECA-79 mAb were bound to the column (data not 
shown).  Sandwich  ELISA  for CD34  also showed that it 
was quantitatively bound to the WGA  column (data not 
shown).  The  eluate  from  the  WGA-Sepharose  column 
was  applied  to  a  MECA-79  mAb-Sepharose  column to 
isolate PNAd. Blotting of the isolated PNAd with MECA- 
79 mAb showed a prominent polypeptide migrating at 105 
kD with additional bands at 60, 165, and 205 kD (Fig. 1 A). 
The  same  bands  with  the  105-kD  band  again prominent 
were visualized by silver staining purified PNAd (Fig. 1 B) 
and after 125I-labeling  (data not shown) (6).  Isolation and 
sequencing of tryptic peptides  from the  105-kD  band re- 
vealed  several  with identity with the  sequence  predicted 
from  the  human  CD34  cDNA,  including  Leu-Gly-Glu- 
Asp-Pro-Tyr-Tyr-Thr-Glu-Asn-Gly,  corresponding to res- 
idues 293-303  (44). 
CD34  in PNAd  was separated  from the other compo- 
nents in this complex glycoprotein mixture to allow their 
relative contributions to L-selectin ligand activity to be in- 
Purl et al. CD34 Is a Major L-Selectin Ligand in Tonsil HEV  263 Figure 1.  Purified  PNAd  and  fractionation  with  CD34  mAb- 
Sepharose. (A) Immunoaffinity-purified PNAd (~1 Ixg)  was elec- 
tophoresed under reducing conditions in SDS 8%  PAGE, and 
electophoretically  transferred  onto  Immobilon-P  membranes 
(Millipore)  that were probed with MECA-79 mAb (5 Ixg/ml) and 
alkaline phosphatase-conjugated mouse anti-rat mAb. (B) Equal 
proportions  of  purified  PNAd,  PNAd  depleted  of  CD34 
(PNAd, CD34-), and CD34 purified from PNAd (PNAd, CD34  +) 
were subjected to SDS 7.5%  PAGE under reducing conditions 
and silver  staining.  Arrowheads denote the band corresponding 
to CD34; lines to the left of A and B denote the position of mark- 
ers: 200, 116, 97.4, 66, and 45 kD. 
vestigated  in  shear flow. PNAd was subjected  to affinity 
chromatography  on  Sepharose  conjugated  to  the  CD34 
mAb 581. This  mAb reacts well with  CD34 expressed  in 
tonsil HEV, in contrast with some mAb that show dimin- 
ished reactivity with this CD34 glycoform, and recognizes 
an epitope that is resistant to neuraminidase and O-sialogly- 
coprotease digestion (17, 18). The band at 105 kD (Fig. 1 
B, arrow) was significantly depleted  in the PNAd,CD34- 
fraction, and was the only band seen in the PNAd,CD34  + 
eluate  fraction. A  capture ELISA was used to quantitate 
CD34 in the different fractions. Protein concentrations of 
the fractions were determined with bicinchoninic acid as- 
say, and the concentration of the CD34 fraction was used 
to  standardize  the  ELISA (Table  I).  CD34 was  30%  of 
PNAd  glycoprotein.  This  was  reduced  to  4%  in  the 
PNAd,CD34- fraction (Table I); thus the extent of CD34 
depletion was 88%. Comparisons of the amount of protein 
in the depleted  and eluted fractions to the starting mate- 
rial  showed quantitative  recoveries  of the  glycoproteins. 
This was also apparent from the silver stained gel in which 
an equal proportion of the fractions was loaded (Fig. 1 B). 
Some  material  migrating  near  to  CD34 remained  in  the 
Table L Protein Preparations 
Protein  Total  CD34  % CD34 
Sample  conc.  Volume  protein  conc.  protein 
I-tg/ml  Ixl  Ixg  txg/ml 
PNAd  29.2  500  14.6  8.8*  30 
PNAd,CD34-  8.1  1250  10.1  0.33*  4.0 
PNAd,CD34 +  3.52  1250  4.4  3.5U  100 
*CD34 ELISA. 
*Protein assay. 
PNAd,CD34- fraction, which may correspond to a distinct 
glycoprotein. 
Tethering in Flow on PNAd Components 
To determine  the contribution of CD34 in PNAd to teth- 
ering  under  laminar  flow  conditions,  lymphocytes  were 
perfused  through  a  parallel  wall  flow  chamber  in  which 
several  concentrations  of  PNAd,CD34-depleted  PNAd 
(PNAd,CD34-)  or  CD34  purified  from  PNAd  (PNAd, 
CD34  ÷) were immobilized. Under continuous flow condi- 
tions freshly purified  lymphocytes tethered  to and rolled 
on  PNAd  and  PNAd  fractions,  but  not  on  HSA-coated 
control substrates. Tethering required Ca  2÷ and was com- 
pletely inhibited  by mAb to L-selectin (Fig. 2).  Compari- 
sons of equal proportions of PNAd (1,460 ng/ml), PNAd, 
CD34- (1;020 ng/ml), and PNAd,CD34 + (440 ng/ml) frac- 
tions, diluted to correspond to the amount of each compo- 
nent in PNAd as a  whole, showed that the PNAd,CD34  ÷ 
fraction  had  slightly  more  tethering  activity  than  the 
PNAd,CD34- fraction and that each had close to 50%  of 
the activity of the PNAd fraction (Fig. 2). 
The  density  of immobilized  CD34  was  similar  in  the 
PNAd (279 sites/txm  2) and PNAd,CD34 ÷  (287 sites/ixm 2) 
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Figure 2.  Lymphocyte tethering in shear flow to PNAd fractions, 
Lymphocytes (5  ×  105  cells/ml)  were  infused  at  varying wall 
shear stresses  through the parallel wall flow chamber. PNAd frac- 
tions  were  immobilized  at  the  indicated  concentrations  and 
yielded the indicated  CD34 site  densities.  Fractions are PNAd; 
CD34 purified from PNAd (PNAd, CD34+); PNAd depleted of 
CD34 (PNAd, CD34-); and  the  recombined PNAd,CD34  ÷ and 
PNAd,CD34- fractions (reconstituted PNAd). CD34 (440 ng/ml) 
and PNAd,CD34- (1,020 ng/rnl)  correspond to the amounts of 
these fractions present in PNAd (1,460 ng/ml).  The number of 
tethers formed per min at a given shear stress was quantitated. 
The data points represent the mean  +  range of the number of 
tethered  lymphocytes in two randomly selected  10×  fields  and 
are representative of three to four different independent experi- 
ments. The presence of mAb DREG-56 to L-selectin or EDTA 
inhibited tethering to all the substrates. 
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tle effect on immobilization of CD34. Tethering efficiency 
was related to the protein concentration used for immobi- 
lization,  and to site density, as shown with three concen- 
trations of the PNAd,CD34 + preparation. To confirm that 
functional activity had not been lost during fractionation 
on CD34 mAb-Sepharose, we also mixed together equal 
proportions of PNAd,CD34-and  PNAd,CD34 + fractions 
(reconstituted  PNAd)  to compare to the starting PNAd. 
Full  activity  was  recovered  in  the  reconstituted  PNAd 
(Fig. 2). Experiments with each fraction diluted two- and 
threefold  further  showed  proportionally  less  tethering, 
and the same overall results, with the PNAd,CD34 + frac- 
tion containing slightly more than half the total PNAd ac- 
tivity. 
Lymphocyte Rolling on PNAd Components 
Having established that CD34 is a major L-selectin tether- 
ing ligand in human tonsil PNAd, we monitored the con- 
tribution  of CD34  to lymphocyte rolling.  The rolling ve- 
locity  of  lymphocytes  decreased  as  the  site  density  of 
immobilized CD34 was increased, suggesting more L-selec- 
tin bonds with the substrate  (Fig.  3).  Rolling velocity in- 
creased as shear stress was increased. The rolling velocities 
for lymphocytes, measured at a range of shear stress val- 
ues,  were  higher  on  the  PNAd,CD34 ÷  (440  ng/ml)  and 
PNAd,CD34- (1,020 ng/ml) fractions than on PNAd (1,460 
ng/ml), showing that both fractions stabilize rolling inter- 
actions. Lymphocytes rolled slightly slower on the PNAd, 
CD34 +  (440  ng/ml)  fraction  than  on  the  PNAd,CD34- 
(1,020 ng/ml) fraction.  Mixing of these  fractions to yield 
the reconstituted PNAd resulted in a lower velocity identi- 
cal to that seen on PNAd. 
Strength of Lymphocyte Adhesion to 
PNAd Components 
To examine further the function of the CD34  and CD34 ÷ 
components of PNAd, we assayed the strength of lympho- 
cyte rolling adhesion as measured by resistance to detach- 
ment by increasing wall shear stress (8, 29). Resistance to 
detachment by shear was dependent on CD34 site density, 
suggesting that the density of CD34 on the plate was re- 
lated to the number of receptor-ligand bonds that could 
form rolling interactions (Fig. 4). Lymphocytes on PNAd 
were  more  resistant  to  shear  detachment  than  on  the 
PNAd,CD34 ÷ and PNAd,CD34-  fractions. Resistance to 
detachment on the PNAd,CD34 ÷ fraction was somewhat 
higher  than  on  the  corresponding  concentration  of the 
PNAd,CD34- fraction, showing a significant participation 
of CD34 compared to the other components in PNAd for 
L-selectin mediated interactions. At two lower concentra- 
tions, rolling adhesions formed on the PNAd,CD34 ÷ frac- 
tion were also more resistant to detachment than on corre- 
sponding  concentrations  of  the  PNAd,CD34-  fraction 
(not  shown).  Reconstituted  PNAd  exhibited  similar  de- 
tachment profiles as PNAd suggesting additive contribu- 
tions of the fractions (Fig. 4). 
CD34  from Different Tissues 
We  isolated  total  tonsillar  CD34;  CD34  from  spleen, 
where lymphocyte homing is L-selectin independent;  and 
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Figure 3.  Lymphocyte rolling on PNAd fractions. Lymphocytes 
were tethered at a  wall shear stress of 0.84 dyn/cm  2 at the indi- 
cated concentrations and site densities of PNAd; CD34 depleted 
PNAd  (PNAd, CD34-);  CD34  purified  from  PNAd  (PNAd, 
CD34+); and reconstituted PNAd. Wall shear stress was then in- 
creased every 10 s to a maximum of 36 dyn/cm  2 and rolling veloc- 
ities  was  measured  as  described  in  experimental  procedures. 
PNAd,CD34 ÷ (440 ng/ml) and PNAd,CD34-  (1,020 ng/ml) cor- 
respond to the amounts present in PNAd (1,460 ng/ml). The data 
points represent the mean rolling velocity _+  the standard error 
of the mean and are representative of three to four different in- 
dependent experiments. 
CD34 from hematopoietic progenitor KGla cells, for com- 
parisons to one another and to the  CD34 component of 
PNAd. Immunoaffinity-purified CD34 from human tonsil 
migrates as a 100-115-kD broad band under reducing (Fig. 
5  A)  and  nonreducing  conditions  (not  shown).  Similar 
amounts of CD34 from spleen and KGla migrated as rela- 
tively sharper bands with slightly lower molecular mass in- 
dicating less heterogeneity in extent of their glycosylation 
(Fig.  5 A). Western blots showed that  CD34 from tonsil 
but not from spleen or KGla cells is reactive with MECA- 
79 mAb (Fig. 5 B). MECA-79 reactivity occurred in a rela- 
tively  higher  molecular  mass  subset  of  the  total  CD34 
from tonsil. 
Lymphocytes  were  perfused  at  a  representative  wall 
shear stress of 0.84 dyn/cm  2 through a parallel plate flow 
chamber to compare tethering to the different CD34 prep- 
arations immobilized at 300 sites/ixm  z (Fig. 6). Total CD34 
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Figure 4.  Resistance to detachment by shear of lymphocytes on 
PNAd fractions.  Lymphocytes were allowed to tether at 0.84 dyn/ 
cmz for 2 to 3 min at the indicated concentrations and site densi- 
ties of PNAd; CD34 depleted PNAd (PNAd, CD34-); CD34 puri- 
fied from PNAd (PNAd, CD34+); and reconstituted PNAd. The 
shear stress was then increased every 10 s to a maximum of 36 
dyn/cm  2 and  the  percentage  of cells  remaining  bound  at  each 
shear  was  determined.  CD34  (440  ng/ml)  and  PNAd,CD34- 
(1,020  ng/ml)  correspond  to  the  amounts  of  these  fractions 
present  in PNAd (1,460  ng/ml).  The data points  represent  the 
mean  _+  range  of the  number  of lymphocytes that  remained 
bound in two randomly selected 10× fields  and are representa- 
tive of three to four different independent experiments. 
from  tonsil  supported  tethering  at  an  efficiency 3.6-fold 
lower than the PNAd,CD34 + fraction; i.e., the MECA-79- 
reactive subset of tonsillar CD34. CD34 from KGla ceils 
supported tethering at an efficiency 8.5-fold lower than the 
PNAd,CD34 + fraction and 2.4-fold lower than total tonsil- 
lar CD34. Though less efficient, tethering to KGla CD34 
was specific as shown by complete inhibition by DREG-56 
mAb to L-selectin, neuraminidase  treatment  (Fig. 6), and 
EDTA (not shown). Furthermore, KGla CD34 supported 
rolling interactions  similar to those on CD34 from tonsil. 
Rolling  velocities  at  2.96  dyn/cm  2 on  the  PNAd,CD34 + 
fraction,  total  tonsillar  CD34,  and  KGla  CD34 were  19, 
35,  and  42  ~m/s,  respectively.  Thus,  KGla  CD34  sup- 
ported tethering  and rolling interactions  through L-selec- 
tin  despite  lack  of  the  MECA-79  epitope.  By  contrast, 
CD34 from spleen supported no tethering or rolling inter- 
actions. 
Figure 5.  SDS-PAGE and Western blot analysis of immunopuri- 
fled CD34.  CD34 was purified from detergent extracts of tonsil, 
spleen,  and  KGla  cells  using  CD34  antibodies  conjugated  to 
Sepharose, as described in experimental procedures.  (A) Similar 
amounts  of CD34  (HI  p~g) each from spleen,  KGla,  and  tonsil 
were subjected  to SDS 7.5%  PAGE under  reducing conditions 
followed  by  silver staining.  (B)  About  0.25  Ixg of each  CD34 
preparation  electrophoresed in  a  similar gel was  electophoreti- 
cally transferred  onto Immobilon-P membrane and probed with 
MECA-79 mAb (5 txg/ml). The bound antibody was detected by 
color developed using an alkaline phosphatase-conjugated mouse 
anti-rat mAb.  MECA-79 reacts with CD34  from tonsil but  not 
from spleen and KGIa cells. 
E-selectin transfectants  were perfused through the par- 
allel plate flow chamber to compare E-selectin  ligand ac- 
tivity of the  CD34 preparations.  The PNAd,CD34 + frac- 
tion and total CD34 from tonsil, KGla cells, and spleen all 
supported  tethering  and  rolling  of E-selectin  transfected 
CHO  cells.  The  adhesion  was  completely  inhibited  by 
BBll  mAb  to  E-selectin  (Fig.  6)  and  required  Ca  ~+  as 
shown  by  complete  inhibition  with  EDTA  (data  not 
shown). Unlike L-selectin, E-selectin did not show a pref- 
erence  for  the  HEV  glycoform  of  CD34  and  bound  to 
CD34 from all sources. 
Characteristics of the Interactions of  L-selectin with the 
PNAd, CD34- and PNAd, CD34  + Fractions 
Inhibitors  and  enzymatic  treatments  were  characterized 
for effect on interactions with the CD34  ÷ and CD34- frac- 
tions  of PNAd.  Certain  anionic  mono-  and  polysaccha- 
rides block L-selectin-dependent  binding (46, 51, 52). Fu- 
coidan  and  heparin  both  inhibited  L-selectin  mediated 
tethering  of lymphocytes to PNAd,CD34 ÷ (Fig. 7).  How- 
ever, the control polysaccharide keratan sulfate was com- 
pletely inactive at a  concentration as high as 30 ixg/ml.  A 
cocktail of 4 mAb to CD34, 547, 563,581, and My-10, had 
no effect on lymphocyte tethering. MECA-79 mAb blocked 
lymphocyte  adhesion  to  both  the  PNAd,CD34 ÷  and 
PNAd,CD34-  fractions by more than 85%,  as previously 
reported for total PNAd (6). 
L-selectin ligands in HEV are sialylated and neuramini- 
dase treatment  abrogates binding (42, 43). Treatment with 
neuraminidases from Vibrio cholera  (Fig. 7) or Newcastle 
disease virus (data not shown) completely prevented lym- 
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Figure 6.  Lymphocyte and E-selectin transfectant 
(CHO-E) cell tethering in hydrodynamic flow to 
CD34  from  different  sources.  Lymphocytes  or 
CHO-E cells (5  x  105 cells/ml) were infused at a 
wall shear stress  of 0.84 dyn/cm  2 on polystyrene 
slides assembled in a parallel plate flow-chamber. 
CD34 purified from PNAd, total CD34 from hu- 
man tonsil, spleen, and KGla cells were adsorbed 
at 440 ng/ml and yielded 287 _+ 35,300 _-2- 37,302 -- 
40, and 295 _+ 30 sites of CD34/~m  2, respectively. 
The number of cells that tethered within the field 
of view per min per mm  2 was calculated. DREG- 
56 mAb to L-selectin and BB-11 mAb to E-selec- 
tin at 10 Ixg/ml completely inhibited tethering of 
lymphocytes,  or CHO-E cells, respectively.  Vibro 
cholera  neuraminidase digestion of  CD34  from 
KGla cells was performed as described in Materi- 
als and Methods.  The data represent the mean _+ 
SD of two  randomly selected lOx fields  and are 
representative of two independent experiments. 
phocyte tethering to  both the  PNAd,CD34  +  and PNAd, 
CD34- fractions. 
O-Sialoglycoprotease  is  an  enzyme  produced  by  the 
bacteria  Pasteurella  hemolytica  (1)  that  selectively  de- 
grades O-sialomucins and has been shown to abolish bind- 
ing of neutrophils to P-selectin (39, 48). Treatment of the 
immobilized PNAd,CD34  ÷  and  PNAd,CD34-  fractions 
with O-sialoglycoprotease inhibited lymphocyte tethering 
by 95 and 92%, respectively (Fig. 7). The few lymphocytes 
that tethered after O-sialoglycoprotease treatment rolled 
only a  few cell diameters after tethering and completely 
detached when the shear stress was raised to 1.5 dyn/cm  2 
(data not shown). These results show that mucin-like do- 
mains are  important for interactions of both the  CD34 ÷ 
and CD34  fractions of PNAd with L-selectin. The cDNA 
sequence of human CD34 predicts nine potential N-glyco- 
sylation sites (20). N-glycanase treatment of the substrates 
did not affect lymphocyte tethering; however, it was diffi- 
cult to determine whether the N-linked glycans had been 
removed because there was little effect on electrophoretic 
mobility (N7  kD)  of the  PNAd,CD34  + fraction in SDS- 
PAGE (data not shown). Endo-13-galactosidase hydrolyzes 
internal  131-4 linkages  between  galactose  and  N-acetyl- 
glucosamine (Ga1131-4GlcNAc) in  extended  unbranched 
poly-N-acetyllactosamine  chains and removes most of the 
poly-N-acetyllactosamine chains  of  the  P-selectin glyco- 
protein ligand from human neutrophils (38). This enzyme 
neither altered the SDS-PAGE mobility of PNAd,CD34  + 
(data not shown) nor affected lymphocyte tethering to the 
CD34 ÷ or CD34- fractions of PNAd (Fig. 7). The enzyme 
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Figure  7.  Characteristics  of  the  interaction 
of  lymphocyte 3  with  PNAd  fractions  under 
flow  conditions.  CD34  purified  from  PNAd 
(PNAd,CD34  +, 440 ng/ml, 287  -+  35 sites/ixm  2) 
and CD34-depleted PNAd  (PNAd,CD34-, 520 
ng/ml) were  adsorbed onto plastic Petri dishes 
and assembled into the flow apparatus. Lympho- 
cytes  (5  x  105 /ml) were perfused through the 
flow chamber at a wall shear stress  of 0.84 dyn/ 
cm  2 and the  number of tethers  in the  field  of 
view formed per minute per mm  2 was calculated. 
Lymphocytes  were  preincubated  with  anionic 
polysaccharides for 5 min in the binding medium 
and infused without dilution into the flow cham- 
ber.  Concentrations of  fucoidan, heparin,  and 
keratan sulfate were 17.5, 20, and 30 ixg/ml, re- 
spectively.  Immobilized  CD34  was  incubated 
with a mixture of CD34 mAbs (10 Ixg/ml each of 
547,563,581, and My-10) for 20 min and flow as- 
say was performed in the presence of these anti- 
bodies (5 Ixg/ml) in the binding medium. Immo- 
bilized PNAd fractions were treated with 20 txg/ 
ml MECA-79 mAb for 30 min and tethering was determined in the continued presence of mAb. Immobilized PNAd fractions were 
treated with indicated glycosidases as described in Materials and Methods. The data represent the mean _  SD of two to three indepen- 
dent experiments normalized to control binding (88 -4- 6 and 58 --- 6 cells per min per mm  2 for PNAd,CD34  + and PNAd,CD34- sub- 
strates, respectively).  Several fields of immobilized substrate were analyzed for sham or N-glycanase and endo-13-galactosidase treat- 
ments. The number of lymphocytes was kept constant in all the above comparisons. 
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tosamine chains or modifications by substitutions such as 
sulfate or fucose that lead to resistance. 
Discussion 
The present study demonstrates that the sialomucin CD34 
can  support  L-selectin-dependent  lymphocyte  adhesive 
interactions  in  shear  flow.  Previous  results  have  shown 
that peripheral lymph node addressin (PNAd), a complex 
mixture of glycoproteins from human tonsil recognized by 
the MECA-79 mAb, mediates lymphocyte binding through 
L-selectin (7, 31). Studies in the murine system have iden- 
tified  two components of PNAd, GlyCAM-1, and  CD34 
(4, 28), but the relative contributions of these two mucin- 
like molecules, and other components of PNAd, to cell ad- 
hesive interactions through L-selectin have been unclear. 
We have determined the contribution of CD34 relative 
to other components in the PNAd complex in mediating 
lymphocyte tethering,  rolling,  and  resistance  to  detach- 
ment in shear.  Furthermore, we have demonstrated that 
CD34 is a prominent component of human PNAd; indeed, 
it appears to correspond to a previously uncharacterized 
105-kD glycoprotein noted to be  a  major component of 
PNAd (6).  We have identified  this  major component as 
CD34 by immunodepletion, and by sequencing of tryptic 
peptides. 
CD34  accounted  for  close  to  30%  of  the  protein  in 
PNAd. CD34 was isolated from PNAd in high purity as 
shown by SDS-PAGE, and this PNAd,CD34  + fraction was 
compared to the CD34-depleted PNAd or PNAd,CD34- 
fraction. ELISA showed at least 88%  depletion of CD34 
from this fraction. Tethering efficiency, a  direct measure 
of the ability of a ligand to mediate interactions with flow- 
ing  cells,  was  reduced  somewhat  more  than  50%  after 
CD34  depletion.  Furthermore,  the  CD34  component of 
PNAd contained somewhat more than 50% of the tether- 
ing activity. Comparing tethering efficiency to protein con- 
tent,  the  PNAd,CD34  +  fraction  is  2.3-fold  more  active 
than the PNAd,CD34- fraction. The caveat is that we do 
not know the efficiency of immobilization of the PNAd, 
CD34-  fraction;  however,  it  clearly  is  immobilized  as 
shown by its  activity, and we suspect that immobilization 
efficiency will  be  similar  to  the  PNAd,CD34  +  fraction. 
Moreover, both the studies with the depleted fraction, and 
the  comparison of the  PNAd,CD34  + fraction  to  PNAd 
and to the reconstituted PNAd fraction, suggest that CD34 
is a major functional component of PNAd. CD34 contains 
an NH2-terminal region of 145 amino acid residues  con- 
taining 35%  serine  and threonine, which is removed by 
O-sialoglycoprotease. This mucin-like domain is followed 
by a globular domain of 66 amino acids and a COOH-ter- 
minal transmembrane domain that remain on the cell sur- 
face after O-sialoglycoprotease or mild protease digestion 
(18, 44). Based on its size in SDS-PAGE, CD34 appears to 
be greater than 60% carbohydrate by weight. Since carbo- 
hydrate determinants on selectin ligands are important for 
selectin recognition (23,  24),  we expect that CD34 has a 
high content of critical carbohydrates efficiently displayed 
in the mucin-like domains that contribute to the avid inter- 
action with L-selectin. Critical carbohydrate modifications 
such as sulfation may also contribute to the more efficient 
binding by CD34; it incorporates a higher amount of sulfa- 
tion  as  shown in  immunoprecipitates with  MECA-79 of 
tonsil stromal lysates metabolically labeled with [35S]504 
(not shown). Furthermore, Western blots with MECA-79 
mAb emphasize the CD34 105-kD band more than silver- 
stained gels (Fig. 1, A  and B). Although displayed on dis- 
tinct  proteins,  the  carbohydrate  ligands  in  both  the 
PNAd,CD34- and PNAd,CD34  ÷ fractions are associated 
with mucin-like domains, as shown by sensitivity to O-sialo- 
glycoprotease. 
We used three independent measures of selectin func- 
tion: tethering,  rolling velocity, and resistance to detach- 
ment in shear. Tethering of a flowing cell to a substrate in- 
volves formation of the first receptor-ligand bond between 
the cell and the substrate, and must be followed by some 
rolling for the tether to persist long enough to be counted. 
Rolling velocity is a function of the kinetics of bond for- 
mation and dissociation and the average number of recep- 
tor-ligand bonds between the cell and the substrate at any 
one time. Resistance to detachment in shear may depend 
more  on  the  average  number  of receptor-ligand  bonds, 
and  how they respond  to  applied  force.  Using  all  three 
measures,  the  CD34  component  of  PNAd  contributed 
more than half the total activity, and was 10-20% more ac- 
tive than the CD34-depleted component of PNAd. Thus, 
there was no evidence for a selective function for CD34 in 
any  of  these  assays.  Reconstitution  experiments  also 
showed  that  the  functions  of  the  PNAd,CD34-  and 
PNAd,CD34  ÷ fractions were  additive rather  than  syner- 
gistic. 
CD34 is widely expressed in the vasculature in both hu- 
man and mouse. It is present on many large and small ves- 
sels  including  postcapillary  venules  and  capillaries  in  a 
wide variety of tissues, as well as on HEV. This has led to 
the hypothesis of the possible role of CD34  in leukocyte 
trafficking  to  both  lymphoid and  nonlymphoid sites  (5, 
12).  CD34 is also expressed on hematopoietic stem cells, 
where its function is unknown. 
We  compared  CD34  isolated  from tonsil,  spleen,  and 
KGla hematopoietic cells.  The CD34 component of ton- 
sillar  PNAd was  more  active  than  total  tonsillar  CD34. 
This may reflect CD34 expression at other sites in tonsil 
besides HEV, as well as the possibility that not all CD34 
expressed in HEV may react with MECA-79 mAb. CD34 
in spleen is present in sparse vascular structures between 
the red and white pulp (5); lymphocyte migration from the 
blood to  spleen  is  known not  to  require  L-selectin  (2). 
Consistent with this, spleen CD34 did not support L-selec- 
tin functions including tethering and rolling, as found pre- 
viously for CD34 transfectants  (40).  Interestingly, KGla 
CD34 possessed substantial  tethering and rolling activity 
as an L-selectin ligand. KGla CD34 was 42 and 12% as ac- 
tive  as  total  tonsillar  CD34  and  PNAd,CD34  ÷ fractions, 
respectively.  KGla  cells  and  KGla  CD34  do  not  react 
with MECA-79 mAb; this dissociates L-selectin ligand ac- 
tivity from MECA-79 reactivity. This is in agreement with 
recent  observations  that  neutrophils  have  an  L-selectin 
ligand that contributes to neutrophil aggregation (45)  and 
can support rolling interactions of one layer of neutrophils 
on another (3).  It is  of further interest  that  all  forms of 
CD34 were active as E-selectin ligands. Previous immuno- 
histochemical and  precipitation  studies  have  shown that 
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HEV  (35)  and bind to purified PNAd  (7).  Furthermore, 
both  L-selectin  and  E-selectin  can  bind  to  sialyl  Lewis  ~ 
and  related  structures,  and  this  has  been  proposed  as a 
minimal recognition motif that requires additional modifi- 
cations (such as sulfation) for optimal recognition (7,  13, 
24). The major capping group of GlyCAM-1  has been de- 
fined as 6'-sulfo sLe  X (21), and the MECA-79 epitope also 
requires  sulfation  (22).  The  finding  that the  MECA-79 + 
PNAd,CD34 + fraction is more active than the MECA-79- 
KGla CD34 is consistent with the importance of sulfation 
in a high-affinity L-selectin ligand. However, our observa- 
tion that KGla  and spleen CD34  are active as E-selectin 
ligands,  yet are active and inactive  as L-selectin  ligands, 
respectively,  implies that a modification that may be dis- 
tinct  from  sulfation,  or  at  least  from  the  MECA-79 
epitope, is also important in modifying a sLe  X  minimal rec- 
ognition motif into an optimal L-selectin ligand.  We have 
unpublished evidence that other molecules besides  CD34 
on  KGla  cells  bear  L-selectin  ligand  activity,  consistent 
with  another  report  (40).  It  remains  to  be  determined 
whether the L-selectin ligand on postcapillary venules in 
nonlymphoid tissues  important in  neutrophil  rolling  (33, 
49) is expressed on CD34,  and whether the carbohydrate 
expressed  on KGla  CD34  will be  similar in structure to 
L-selectin ligands expressed on these MECA-79  venules 
and on neutrophils (3). 
In  summary, our  data  provide  the  first  demonstration 
that sialomucin CD34 mediates cell adhesion and supports 
lymphocyte tethering and rolling under in vitro flow con- 
ditions. We show that CD34 is the predominant L-selectin 
ligand in the mixture of peripheral node addressins from 
human tonsil. Furthermore, HEV specific glycosylation is 
required for high affinity binding to L-selectin. A  modifi- 
cation distinct from the MECA-79 epitope can also modu- 
late L-selectin  ligand  and differentiate  it from E-selectin 
ligand activity. Further studies, such as comparison of the 
differential  glycosylation  responsible  for  the  L-selectin 
binding  activity of CD34 from tonsil but not from spleen 
will further our understanding of modulation of L-selectin 
ligand activities. 
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